Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 706-715
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.706
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.706
Table 1 Patient demographics
| Clinicopathologic features | Value (%) |
| Mean age (range), yr | 51.3 ± 13.1 (30-84) |
| Sex, male/female | |
| Male | 19 (68) |
| Female | 9 (32) |
| Tumor location | |
| Bulb | 2 (7) |
| Descending section | 16 (57) |
| Horizontal section | 9 (32) |
| Ascending section | 1 (4) |
| Surgical technique | |
| Open surgery | 13 (46) |
| Robotic surgery | 15 (54) |
| Types of resection | |
| Limited resection | 17 (61) |
| PD | 11 (39) |
| Tumor size (cm) | |
| ≤ 2 | 2 (7) |
| 2-5 | 17 (61) |
| 5-10 | 7 (25) |
| > 10 | 2 (7) |
| Risk assessment (NIH 2008) | |
| Low | 19 (68) |
| Medium | 5 (18) |
| High | 4 (14) |
| Resection margin status | |
| R0 | 28 (100) |
| R1 | 0 |
| Postoperative targeted drug therapy | |
| Yes | 9 (32) |
| No | 19 (68) |
| Postoperative recurrence and metastasis | |
| Yes | 4 (14) |
| No | 24 (86) |
Table 2 Comparison of patients in the open surgery group and robotic surgery group (n = 28)
| No. of patients | P value | ||
| Open | Robotic | ||
| Total patients | 13 | 15 | |
| Age | 0.718 | ||
| ≥ 50 yr | 8 | 8 | |
| < 50 yr | 5 | 7 | |
| Sex | 0.689 | ||
| Male | 8 | 11 | |
| Female | 5 | 4 | |
| Tumor size | 0.255 | ||
| < 5 cm | 5 | 10 | |
| ≥ 5 cm | 8 | 5 | |
| Surgical technique | 0.700 | ||
| Limited resection | 7 | 10 | |
| PD | 6 | 5 | |
| OT (min) | 0.029 | ||
| mean ± SD 1 | 207.7 ± 63.1 | 156.0 ± 55.4 | |
| EBL (mL) | 0.01 | ||
| mean ± SD 1 | 340.0 ± 401.8 | 62.3 ± 34.9 | |
| PHS (d) | 0.294 | ||
| mean ± SD 1 | 16 ± 9.4 | 15.7 ± 13.4 | |
| Mitotic count (/50 HPF) | 1.000 | ||
| ≤ 5 | 12 | 14 | |
| > 5 | 1 | 1 | |
| Risk assessment | 0.072 | ||
| Low | 6 | 13 | |
| Medium | 4 | 1 | |
| High | 3 | 1 | |
| POPC | 1.000 | ||
| Yes | 7 | 7 | |
| No | 6 | 8 | |
| Postoperative targeted therapy | 1.000 | ||
| Yes | 4 | 5 | |
| No | 9 | 10 | |
| Recurrence/metastasis | 0.311 | ||
| Yes | 3 | 1 | |
| No | 10 | 14 | |
Table 3 General information on patients with recurrence and metastasis (n = 4)
| Patient, No./sex/age, yr | Tumor location | Operation | Recurrent time (mo) | Recurrent location | Risk of disease progression |
| 1/M/75 | Descending section | RPD | 21 | Liver | Medium |
| 2/M/61 | Horizontal section | PD | 36 | Mesocolon | High |
| 3/M/50 | Descending section | PD | 108 | Liver | Medium |
| 4/M/56 | Descending section | PD | 60 | Liver | Medium |
- Citation: Zhou ZP, Tan XL, Zhao ZM, Gao YX, Song YY, Jia YZ, Li CG. Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre. World J Gastrointest Oncol 2021; 13(7): 706-715
- URL: https://www.wjgnet.com/1948-5204/full/v13/i7/706.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i7.706
